55658-71-4

Basic information

• Product Name: methyl (1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1 -en-2- yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylate
• Synonyms: methyl (1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1 -en-2- yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylate
• CAS NO: 55658-71-4
• Molecular Weight: 372.505
• Mol File: 55658-71-4.mol
• Article Data: 17

Chemical Properties

• CAS DataBase Reference: methyl (1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1 -en-2- yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl (1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1 -en-2- yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylate(55658-71-4)
• EPA Substance Registry System: methyl (1'R,2'R)-2,6-dihydroxy-5'-methyl-4-pentyl-2'-(prop-1 -en-2- yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-3-carboxylate(55658-71-4)

Safety Data

• Hazardous Substances Data: 55658-71-4(Hazardous Substances Data)

Upstream product

• 186581-53-3 diazomethane 
• 13956-29-1 CBD 
• 22972-51-6 (1S,4R)-p-mentha-2,8-dien-1-ol 
• 58016-28-7 methyl 2,6-dihydroxy-6-pentylbenzoate 
• 52154-82-2 (1R,4R)-p-mentha-2,8-dien-1-ol 
• 861892-40-2 (4R)-1-methyl-4-(2-(1-propylene))-2-cyclohexene-2-ol 
• 67-56-1 methanol 
• 1244-58-2 cannabidiolic acid 

Downstream Products

• 1972-08-3 dronabinol 
• 13956-29-1 CBD 
• 23978-85-0 tetrahydrocannabinolic acid 
• 1244-58-2 cannabidiolic acid 
• 74219-29-7 (1'S,2'S)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol 

Relevant articles and documents

Method for preparing cannabinoids

Provided is a method for preparing synthetic cannabidiol, including hydrolysis-decarboxylation of a compound represented by formula (II) in a solvent-free state under atmospheric pressure. The method further includes preparation of the compound represented by formula (II). The method provides a safe, economical, environmentally friendly and scalable method for synthetic preparation of cannabidiol.

CANNABIDIOLIC ACID ESTERS FOR TREATING MUSCULAR DYSTROPHY

The present invention provides compositions and methods for treating muscular dystrophy. In particular, the present invention provides pharmaceutical compositions and formulations comprising a cannabidiolic acid (CBDA) ester alone or in combination with o

CANNABIDIOLIC ACID (CBDA) DERIVATIVES AND USES THEREOF

The present invention provides novel compounds comprising cannabidiolic acid (CBDA) derivatives, including acids and esters, and uses thereof in the treatment of various diseases, disorders, conditions and symptoms.